Analysis published 16 May 2026

AI-generated · cited to primary sources · not investment advice

UTI AMC (543238) Oct 2025 Filing Analysis

01 · Management Credibility

Does management do what it says?

MetEquity Mix in AUM
85/100

The company successfully launched the fourth fund in the SDOF series during Q2 FY26. (1 met across 1 tracked commitment)

We have launched the fourth fund of our SDOF series in quarter 2 and this fund has been planned as a Rs. 1,500 crore fund.

UTI AMC · Concall Transcript · Oct 2025 · p.7
MissedOther Findings
63/100

The effective tax rate for FY26 was approximately 26.9% (calculated from PBT of 553 Cr and PAT of 404 Cr), falling within the guided range. (3 met, 2 missed across 5 tracked commitments)

So for the full year, we maintain a guidance of close to around 7%-8% for the other expenses.

UTI AMC · Concall Transcript · Oct 2025 · p.10
In progressNet SIP Flow Metrics
60/100

Management noted that while market share in SIPs dipped slightly (2.9% to 2.7%), they are seeing a pick-up in performance in growth-oriented schemes over the last year and expect flows to follow with a 2-3 year 'sweet spot' lag. (1 in progress across 1 tracked commitment)

Strong focus on growing SIP book Digitally

UTI AMC · Investor PPT · Oct 2025 · p.20
MetDistribution Network Breadth
58/100

The company failed to reach the target of 40 branches for UTI Pension Fund Limited by the end of FY26, ending the year with 32 branches. (1 missed, 1 met across 2 tracked commitments)

We currently operate through 31 branches across India and plan to take the total number of branches to 40 in FY26.

UTI AMC · Concall Transcript · Oct 2025 · p.6
MissedEBITDA Margin Percentage
30/100

Consolidated employee benefit expenses for H1 FY26 increased by 26% YoY, significantly exceeding the guided 400-500 bps (4-5%) growth range. This was partly due to a one-time impact of ₹ 25 crore for family pension revision. (4 missed across 4 tracked commitments)

Employee Benefit Expense1 ... H1 FY26 288 [cr] H1 FY25 229 [cr] YoY (%) 26%

UTI AMC · Investor PPT · Oct 2025 · p.14

See the full cited Management analysis of UTI AMC

Create free account →
04 · Risk

What could break the thesis?

Equity Mix in AUM

The Equity market share has deteriorated further to 2.93% from 3.32% YoY. Since equity is the highest-margin product, this mix shift negatively impacts the blended revenue yield. (2 intensifying, 3 easing)

Equity... Sep'24 3.32% [to] Sep'25 2.93%

UTI AMC · Investor PPT · Oct 2025 · p.8
Net SIP Flow Metrics

STABLE. Market share in gross sales is holding at 6.4% for H1 FY26. However, SIP market share has dipped slightly from 2.9% to 2.7% YoY, which is a critical lead indicator for future AUM. (2 stable)

If I look at the SIP market share, which was there in September 2024, which was about 2.9% and now it is about 2.7%.

UTI AMC · Concall Transcript · Oct 2025 · p.10

See the full cited Risk analysis of UTI AMC

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.